IN8bio, Inc.

INAB Stock Healthcare Biotechnology
$1.09
-0.01 (-0.91%)
Price as of Sep 01, 2026 market close

Performance

1 Month
+13.5%
3 Months
-30.1%
YTD
-53.4%
1 Year
-50.7%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
85.0%
Largest decline max drawdown, since Aug 2025
-62.9%
Risk-adjusted return Sharpe ratio, 1-year
-0.42

Own INAB?

See how INAB contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.